Cost- effectiveness analysis of nevirapine vs. Ritonavir-boosted lopinavir in hiv-infected children with peripartum nevirapine exposure, in resource-constrained areas from a payer’s perspective
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1395
https://www.valueinhealthjournal.com/article/S1098-3015(15)01452-7/fulltext
Title :
Cost- effectiveness analysis of nevirapine vs. Ritonavir-boosted lopinavir in hiv-infected children with peripartum nevirapine exposure, in resource-constrained areas from a payer’s perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01452-7&doi=10.1016/j.jval.2015.03.1395
First page :
A240
Section Title :
Infection
Open access? :
No
Section Order :
864